Related Experiment Video
Updated: May 2, 2026
10:59
Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
Published on: February 7, 2025
1.7K
Implications of glycoprotein VI for theranostics
M Gawaz1, S Vogel, C Pfannenberg
1Meinrad Gawaz, MD, Department of Cardiology, University of Tübingen, Otfried-Müller-Straße 10, 72076 Tübingen, Germany, Tel.: +49 7071 29 83688, Fax: +49 7071 29 5749,
Thrombosis and Haemostasis
|February 21, 2014
Summary
Glycoprotein VI (GPVI) on platelets indicates cardiovascular disease risk. Soluble GPVI (sGPVI-Fc) shows potential for diagnosing and treating vascular lesions using molecular imaging.
Area of Science:
- Cardiovascular Medicine
- Molecular Imaging
- Biochemistry
Background:
- Glycoprotein VI (GPVI) is crucial for platelet activation and thrombus formation.
- Elevated GPVI surface expression on platelets is observed in acute cardiovascular diseases like myocardial infarction and stroke.
- Increased GPVI levels correlate with poor clinical outcomes and predict myocardial infarction.
Purpose of the Study:
- To review the diagnostic and therapeutic potential of GPVI in cardiovascular diseases.
- To explore novel non-invasive molecular imaging modalities utilizing GPVI.
- To enhance patient care for cardiovascular diseases through GPVI-based strategies.
Main Methods:
- Review of recent studies on GPVI in cardiovascular diseases.
- Analysis of soluble GPVI-Fc (sGPVI-Fc) binding to collagen and atherosclerotic plaques.
- Evaluation of non-invasive imaging studies using radiolabeled sGPVI-Fc.
Main Results:
- sGPVI-Fc exhibits high affinity for collagen and atherosclerotic plaque.
- In vivo imaging demonstrates specific binding of sGPVI-Fc to vascular lesions.
- sGPVI-Fc is being developed for targeted antithrombotic therapy.
Conclusions:
- GPVI holds significant potential for diagnostic applications in cardiovascular diseases.
- sGPVI-Fc offers a promising therapeutic strategy for lesion-directed antithrombotic treatment.
- Non-invasive molecular imaging of GPVI can improve cardiovascular disease management.
